Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

Market Cap	5.31B -14.4%
Revenue (ttm)	3.37B -3.9%
Net Income	359.84M -0.6%
EPS	2.37 -0.4%
Shares Out	153.40M
PE Ratio	14.62
Forward PE	n/a
Dividend	0.90 (2.60%)
Ex-Dividend Date	Apr 30, 2025

Volume	3,827,600
Average Volume	3,155,424
Open	34.62
Previous Close	34.64
Day's Range	33.69 - 35.17
52-Week Range	31.03 - 48.14
Beta	0.35
RSI	53.61
Earnings Date	Mar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1637
• Employees: 2,257
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600976

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.